RS Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

RS Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$26.9M	Sell	366,010 -159,990	-30%	-$11.3M	0.28%	136
2016 Q1	$33.6M	Buy	526,000 +4,950	+1%	+$312K	0.33%	112
2015 Q4	$35.8M	Sell	521,050 -1,600	-0.3%	-$106K	0.32%	108
2015 Q3	$30.9M	Buy	522,650 +171,590	+49%	+$10.9M	0.28%	133
2015 Q2	$23.4M	Buy	+351,060	New	+$23.1M	0.2%	173

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

RS Investment Management's BMY Position: Q2 2016 in Review

RS Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 30% in Q2 2016, selling an estimated $11.3M and leaving 366,010 shares worth $26.9M. The position accounts for 0.28% of the portfolio, ranked #136.

RS Investment Management first reported a position in BMY in Q2 2015 and has held it in 5 quarters since. The position peaked at $35.8M in Q4 2015. 1,577 funds tracked by Wall St. Rank hold BMY as of Q2 2016.

RS Investment Management held 366,010 shares of Bristol-Myers Squibb worth $26.9M as of Q2 2016.
RS Investment Management sold 159,990 Bristol-Myers Squibb shares in Q2 2016, an estimated $11.3M.
Bristol-Myers Squibb made up 0.28% of RS Investment Management's portfolio in Q2 2016, its #136 holding.
RS Investment Management first reported a position in Bristol-Myers Squibb in Q2 2015 and has held it in 5 quarters since.
RS Investment Management's Bristol-Myers Squibb position peaked at $35.8M in Q4 2015.
1,577 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.